18-Oct-2026 15:50:31
Govt Caps Margins on 137 Cancer Drugs at 30%; Patients Could Save ₹2,500 Crore Annually
The government has capped trade margins at 30% for 137 non-scheduled anti-cancer drugs, with revised prices effective November 9, 2026. The National Pharmaceutical Pricing Authority expects the move to reduce medicine prices by up to 70%, potentially saving patients around ₹2,500 crore annually. The measure aims to make cancer treatment more affordable and improve access to essential medicines. The price-control decision covers medicines used in cancer care and seeks to curb excessive mark-ups across the drug distribution chain.